Loomis, Sayles & Company’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.4M Buy
1,200,239
+224,792
+23% +$8.09M 0.07% 108
2026
Q1
$31.4M Sell
975,447
-81,258
-8% -$2.89M 0.04% 162
2025
Q4
$38.1M Buy
1,056,705
+50,967
+5% +$1.87M 0.05% 143
2025
Q3
$31.7M Sell
1,005,738
-25,965
-3% -$932K 0.04% 165
2025
Q2
$43.9M Sell
1,031,703
-25,026
-2% -$1.04M 0.06% 121
2025
Q1
$47.2M Buy
1,056,729
+46,183
+5% +$2.49M 0.07% 110
2024
Q4
$55.5M Sell
1,010,546
-29,524
-3% -$1.49M 0.07% 110
2024
Q3
$43.9M Sell
1,040,070
-23,930
-2% -$1.14M 0.06% 149
2024
Q2
$48.8M Sell
1,064,000
-42,301
-4% -$1.99M 0.07% 118
2024
Q1
$57.5M Sell
1,106,301
-35,225
-3% -$1.54M 0.08% 105
2023
Q4
$40.6M Sell
1,141,526
-36,134
-3% -$1.26M 0.06% 147
2023
Q3
$39.5M Sell
1,177,660
-36,755
-3% -$1.27M 0.07% 140
2023
Q2
$45.6M Sell
1,214,415
-11,231
-0.9% -$369K 0.07% 122
2023
Q1
$35.9M Buy
1,225,646
+242,609
+25% +$7.03M 0.06% 148
2022
Q4
$25.9M Sell
983,037
-23,513
-2% -$560K 0.05% 191
2022
Q3
$23.4M Buy
1,006,550
+186,477
+23% +$5.09M 0.05% 195
2022
Q2
$20.6M Buy
820,073
+166,533
+25% +$4.92M 0.04% 242
2022
Q1
$25M Sell
653,540
-12,466
-2% -$450K 0.03% 254
2021
Q4
$26.2M Buy
+666,006
New +$29.2M 0.03% 270

Other funds holding VCEL

Loomis, Sayles & Company's VCEL Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Vericel Corp (VCEL) stake by 23% in Q2 2026, buying an estimated $8.09M and bringing the position to 1,200,239 shares worth $53.4M. The position accounts for 0.07% of the portfolio, ranked #108.

Loomis, Sayles & Company first reported a position in VCEL in Q4 2021 and has held it in 19 quarters since. The position peaked at $57.5M in Q1 2024. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Loomis, Sayles & Company held 1,200,239 shares of Vericel Corp worth $53.4M as of Q2 2026.
  • Loomis, Sayles & Company bought 224,792 Vericel Corp shares in Q2 2026, an estimated $8.09M.
  • Vericel Corp made up 0.07% of Loomis, Sayles & Company's portfolio in Q2 2026, its #108 holding.
  • Loomis, Sayles & Company first reported a position in Vericel Corp in Q4 2021 and has held it in 19 quarters since.
  • Loomis, Sayles & Company's Vericel Corp position peaked at $57.5M in Q1 2024.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.